Redeye shares its preview for RaySearch’s Q1 2025 report, due May 9.
Redeye comments on Alligator's first quarter 2025, during which a rights issue of gross SEK150m was ...
Redeye provides its initial take on Heliospectra’s Q1 results, noting that while sales were below ex...
Sales -1% and adj. EBIT -18% vs. ABGSCe Operating cash flow significantly better than expected Likel...
Dynavox delivered a robust Q1, with sales coming in 16% above our forecast and 13% ahead of consensu...
Sales -7% vs. ABGSCe at SEK 32m EBITDA better than expected (SEK -0.
Redeye believes investors overreacted to Enea’s Q1 2025 report, sending the stock down ~19% due to a...
Following the announcement on March 28th that Skalhuset AB is entering reorganization, Redeye is sus...
Redeye provides its initial take on Lifco’s Q1 2025 report, which came in roughly in line with our e...
Q1 is spot on expectations in most aspects. The organic CER growth of 14% is expected to improve wit...
Redeye updates its outlook on Stille following a report that missed expectations due to temporary su...
Redeye views the Q1 2025 report as solid and broadly in line with expectations.
Revenue was down 3% y/y in Q1, but Scanfil kept its full-year revenue guidance unchanged and expects...
We lower adjusted EBITA by 6-13% for 2025E-27E following the Q1 report, which was weaker than expect...
